Source:http://linkedlifedata.com/resource/pubmed/id/16775036
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2006-6-26
|
pubmed:abstractText |
A heterozygous mutation in autosomal Alport genes COL4A3 and COL4A4 can be found in 20 to 50% of individuals with familial benign hematuria and diffuse glomerular basement membrane thinning (thin basement membrane nephropathy [TBMN]). Approximately 1% of humans are heterozygous carriers of mutations in the autosomal Alport genes and at risk for developing renal failure as a result of TBMN. The incidence and pathogenesis of renal failure in heterozygous COL4A3/4 mutation carriers is still unclear and was examined further in this study using COL4A3 knockout mice. In heterozygous COL4A3(+/-) mice lifespan, hematuria and renal function (serum urea and proteinuria) were monitored during a period of 3 yr, and renal tissue was examined by light and electron microscopy, immunohistochemistry, and Western blot. Lifespan of COL4A3(+/-) mice was found to be significantly shorter than in healthy controls (21.7 versus 30.3 mo). Persistent glomerular hematuria was detected starting in week 9; proteinuria of > 0.1 g/L started after 3 mo of life and increased to > 3 g/L after 24 mo. The glomerular basement membrane was significantly thinned (167 versus 200 nm in wild type) in 30-wk-old mice, coinciding with focal glomerulosclerosis, tubulointerstitial fibrosis, and increased levels of TGF-beta and connective tissue growth factor. The renal phenotype in COL4A3(+/-) mice resembled the clinical and histopathologic phenotype of human cases of TBMN with concomitant progression to chronic renal failure. Therefore, the COL4A3(+/-) mouse model will help in the understanding of the pathogenesis of TBMN in humans and in the evaluation of potential therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type IV,
http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tgfb1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1046-6673
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1986-94
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16775036-Aging,
pubmed-meshheading:16775036-Animals,
pubmed-meshheading:16775036-Collagen Type IV,
pubmed-meshheading:16775036-Disease Models, Animal,
pubmed-meshheading:16775036-Extracellular Matrix,
pubmed-meshheading:16775036-Glomerular Basement Membrane,
pubmed-meshheading:16775036-Glomerulonephritis, Membranous,
pubmed-meshheading:16775036-Kidney,
pubmed-meshheading:16775036-Kidney Failure, Chronic,
pubmed-meshheading:16775036-Longevity,
pubmed-meshheading:16775036-Mice,
pubmed-meshheading:16775036-Mice, Transgenic,
pubmed-meshheading:16775036-Nephritis, Hereditary,
pubmed-meshheading:16775036-Phenotype,
pubmed-meshheading:16775036-Transforming Growth Factor beta,
pubmed-meshheading:16775036-Transforming Growth Factor beta1
|
pubmed:year |
2006
|
pubmed:articleTitle |
Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
|
pubmed:affiliation |
Medical Faculty University of Cologne, Medicine Clinic I, Hospital Merheim, Ostmerheimer Strasse 200, D-51109 Cologne, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|